Next-Generation Advances in Prostate Cancer Imaging and Artificial Intelligence Applications
Journal of Imaging · 03.11.2025 · 11 (11) · 390
DOI: 10.3390/jimaging11110390 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Imaging, online erschienen am 03.11.2025. Verfasst von Kathleen H Miao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer is one of the leading causes of cancer-related morbidity and mortality worldwide, and imaging plays a critical role in its detection, localization, staging, treatment, and management. The advent of artificial intelligence (AI) has introduced transformative possibilities in prostate imaging, offering enhanced accuracy, efficiency, and consistency. This review explores the integration of AI in prostate cancer diagnostics across key imaging modalities, including multiparametric MRI (mpMRI), PSMA PET/CT, and transrectal ultrasound (TRUS). Advanced AI technologies, such as machine learning, deep learning, and radiomics, are being applied for lesion detection, risk stratification, segmentation, biopsy targeting, and treatment planning. AI-augmented systems have demonstrated the ability to support PI-RADS scoring, automate prostate and tumor segmentation, guide targeted biopsies, and optimize radiation therapy. Despite promising performance, challenges persist regarding data heterogeneity, algorithm generalizability, ethical considerations, and clinical implementation. Looking ahead, multimodal AI models integrating imaging, genomics, and clinical data hold promise for advancing precision medicine in prostate cancer care and assisting clinicians, particularly in underserved regions with limited access to specialists. Continued multidisciplinary collaboration will be essential to translate these innovations into evidence-based practice. This article explores current AI applications and future directions that are transforming prostate imaging and patient care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Radiology, University of Chicago Medicine, Chicago, IL 60637, USA.
ORCID-Profile: Aritrick Chatterjee
Zitieren
APA
Miao, K. H., Miao, J. H., Finkelstein, M., Chatterjee, A., & Oto, A. (2025). Next-Generation Advances in Prostate Cancer Imaging and Artificial Intelligence Applications. Journal of Imaging, 11(11), 390. https://doi.org/10.3390/jimaging11110390
Vancouver
Miao KH, Miao JH, Finkelstein M, Chatterjee A, Oto A. Next-Generation Advances in Prostate Cancer Imaging and Artificial Intelligence Applications. Journal of Imaging. 2025;11(11):390. doi:10.3390/jimaging11110390
BibTeX
@article{Miao2025,
author = {Miao, Kathleen H and Miao, Julia H and Finkelstein, Mark and Chatterjee, Aritrick and Oto, Aytekin},
title = {Next-Generation Advances in Prostate Cancer Imaging and Artificial Intelligence Applications},
journal = {Journal of Imaging},
year = {2025},
volume = {11},
number = {11},
pages = {390},
doi = {10.3390/jimaging11110390}
}
EUVIMED